Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histiocytosis, Langerhans-Cell | 47 | 2023 | 261 | 13.300 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 25 | 2023 | 184 | 5.800 |
Why?
|
Langerhans Cells | 7 | 2021 | 50 | 2.520 |
Why?
|
Proto-Oncogene Proteins B-raf | 16 | 2023 | 1283 | 2.060 |
Why?
|
Xanthogranuloma, Juvenile | 7 | 2022 | 38 | 2.060 |
Why?
|
Histiocytosis, Sinus | 6 | 2022 | 86 | 1.470 |
Why?
|
Dendritic Cells | 13 | 2023 | 1085 | 1.420 |
Why?
|
Ferritins | 6 | 2021 | 151 | 1.190 |
Why?
|
Macrophage Activation Syndrome | 3 | 2023 | 11 | 1.110 |
Why?
|
Erdheim-Chester Disease | 5 | 2023 | 53 | 1.090 |
Why?
|
Mannose-Binding Lectins | 8 | 2020 | 29 | 1.060 |
Why?
|
Lectins, C-Type | 8 | 2020 | 162 | 0.990 |
Why?
|
Neurodegenerative Diseases | 3 | 2018 | 264 | 0.930 |
Why?
|
Cell Differentiation | 9 | 2023 | 4078 | 0.910 |
Why?
|
Child | 62 | 2024 | 29154 | 0.880 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2024 | 489 | 0.870 |
Why?
|
Myeloid Cells | 4 | 2023 | 269 | 0.810 |
Why?
|
Herpesvirus 4, Human | 5 | 2024 | 966 | 0.810 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 709 | 0.750 |
Why?
|
Zinc Fingers | 7 | 2011 | 205 | 0.750 |
Why?
|
Histiocytosis | 5 | 2020 | 54 | 0.740 |
Why?
|
Sarcoma, Kaposi | 4 | 2023 | 187 | 0.730 |
Why?
|
Sepsis | 4 | 2021 | 652 | 0.730 |
Why?
|
MAP Kinase Signaling System | 7 | 2021 | 848 | 0.730 |
Why?
|
Antigens, CD | 7 | 2020 | 1385 | 0.710 |
Why?
|
Disease Susceptibility | 2 | 2022 | 538 | 0.700 |
Why?
|
Humans | 127 | 2024 | 261506 | 0.690 |
Why?
|
T-Lymphocytes | 7 | 2024 | 3869 | 0.680 |
Why?
|
Mutation | 19 | 2023 | 15179 | 0.670 |
Why?
|
Interleukin-17 | 2 | 2011 | 250 | 0.650 |
Why?
|
Transplantation Conditioning | 5 | 2020 | 2238 | 0.640 |
Why?
|
Smad6 Protein | 1 | 2017 | 14 | 0.630 |
Why?
|
DNA-Binding Proteins | 11 | 2011 | 4821 | 0.620 |
Why?
|
Interleukin-18 | 1 | 2018 | 100 | 0.620 |
Why?
|
Osteopontin | 1 | 2018 | 148 | 0.610 |
Why?
|
Child, Preschool | 34 | 2023 | 16273 | 0.590 |
Why?
|
Infant | 27 | 2023 | 13310 | 0.590 |
Why?
|
Precision Medicine | 3 | 2022 | 1154 | 0.580 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2023 | 6550 | 0.580 |
Why?
|
Cell Movement | 2 | 2021 | 2466 | 0.550 |
Why?
|
Lymphoma | 3 | 2023 | 1467 | 0.520 |
Why?
|
Histiocytes | 3 | 2022 | 94 | 0.520 |
Why?
|
Hodgkin Disease | 6 | 2023 | 1429 | 0.510 |
Why?
|
Protein Kinase Inhibitors | 8 | 2022 | 4757 | 0.510 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2014 | 16 | 0.510 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 16 | 0.510 |
Why?
|
Skin Diseases | 2 | 2015 | 349 | 0.500 |
Why?
|
Lymphoproliferative Disorders | 3 | 2024 | 366 | 0.500 |
Why?
|
Cell Degranulation | 1 | 2014 | 47 | 0.500 |
Why?
|
Epistasis, Genetic | 1 | 2014 | 119 | 0.480 |
Why?
|
Adolescent | 35 | 2023 | 31252 | 0.470 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2022 | 639 | 0.450 |
Why?
|
Antigens, CD1 | 4 | 2020 | 49 | 0.450 |
Why?
|
Cytokines | 7 | 2021 | 2809 | 0.440 |
Why?
|
Lymphocytes | 2 | 2015 | 1234 | 0.430 |
Why?
|
Alemtuzumab | 5 | 2023 | 198 | 0.430 |
Why?
|
Central Nervous System Diseases | 2 | 2010 | 129 | 0.420 |
Why?
|
Molecular Targeted Therapy | 3 | 2017 | 2330 | 0.420 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1046 | 0.420 |
Why?
|
Genome-Wide Association Study | 3 | 2020 | 2265 | 0.410 |
Why?
|
NF-kappa B | 5 | 2007 | 1549 | 0.400 |
Why?
|
Herpesvirus 8, Human | 2 | 2023 | 102 | 0.400 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 755 | 0.390 |
Why?
|
Leukemia | 1 | 2020 | 1635 | 0.390 |
Why?
|
Interferon-gamma | 3 | 2022 | 1144 | 0.380 |
Why?
|
Genetic Predisposition to Disease | 4 | 2021 | 5539 | 0.370 |
Why?
|
Models, Genetic | 2 | 2014 | 1113 | 0.370 |
Why?
|
Autoimmune Diseases | 3 | 2020 | 402 | 0.370 |
Why?
|
Perforin | 3 | 2021 | 52 | 0.370 |
Why?
|
Hydrocephalus | 2 | 2010 | 217 | 0.360 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2023 | 1039 | 0.350 |
Why?
|
Epidermis | 1 | 2010 | 188 | 0.350 |
Why?
|
Male | 50 | 2023 | 123000 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 1586 | 0.340 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2020 | 79 | 0.340 |
Why?
|
Biomarkers | 7 | 2021 | 5047 | 0.340 |
Why?
|
Whole Genome Sequencing | 1 | 2020 | 338 | 0.320 |
Why?
|
Diagnosis, Differential | 6 | 2021 | 4744 | 0.320 |
Why?
|
Cytarabine | 2 | 2015 | 1973 | 0.310 |
Why?
|
Enzyme Activation | 3 | 2016 | 1764 | 0.310 |
Why?
|
Transcription Factors | 8 | 2020 | 5270 | 0.310 |
Why?
|
Hematologic Diseases | 2 | 2020 | 242 | 0.310 |
Why?
|
Female | 49 | 2023 | 141928 | 0.310 |
Why?
|
Transforming Growth Factor beta | 3 | 2017 | 1130 | 0.310 |
Why?
|
Vincristine | 2 | 2020 | 1511 | 0.300 |
Why?
|
Models, Biological | 4 | 2014 | 3254 | 0.300 |
Why?
|
Lymphoma, T-Cell | 2 | 2021 | 361 | 0.290 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 173 | 0.290 |
Why?
|
HIV Infections | 4 | 2023 | 2134 | 0.290 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2021 | 182 | 0.290 |
Why?
|
Monocytes | 3 | 2023 | 788 | 0.290 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2020 | 160 | 0.280 |
Why?
|
Neoplasms | 6 | 2023 | 15193 | 0.280 |
Why?
|
Biopsy | 4 | 2021 | 3443 | 0.280 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 246 | 0.270 |
Why?
|
Vinblastine | 3 | 2016 | 453 | 0.270 |
Why?
|
Genes, ras | 1 | 2008 | 667 | 0.260 |
Why?
|
Prednisone | 4 | 2016 | 984 | 0.260 |
Why?
|
Hematologic Neoplasms | 4 | 2018 | 1870 | 0.260 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 582 | 0.250 |
Why?
|
Genome | 1 | 2008 | 672 | 0.250 |
Why?
|
Hematopoietic Stem Cells | 4 | 2021 | 1242 | 0.250 |
Why?
|
Burkitt Lymphoma | 2 | 2020 | 335 | 0.250 |
Why?
|
Adult | 28 | 2023 | 77950 | 0.250 |
Why?
|
Immune System Diseases | 2 | 2017 | 65 | 0.240 |
Why?
|
Recombination, Genetic | 3 | 2002 | 613 | 0.240 |
Why?
|
Disease Management | 5 | 2021 | 1052 | 0.230 |
Why?
|
Animals | 23 | 2021 | 59536 | 0.230 |
Why?
|
Enhancer Elements, Genetic | 3 | 2002 | 467 | 0.230 |
Why?
|
Kasabach-Merritt Syndrome | 1 | 2023 | 16 | 0.220 |
Why?
|
Immunoglobulin Fragments | 1 | 2002 | 28 | 0.220 |
Why?
|
Antibodies, Monoclonal, Humanized | 3 | 2023 | 3251 | 0.220 |
Why?
|
Rheumatology | 1 | 2023 | 72 | 0.220 |
Why?
|
Adenovirus Infections, Human | 1 | 2023 | 56 | 0.220 |
Why?
|
Protein Sorting Signals | 1 | 2002 | 44 | 0.220 |
Why?
|
Infant, Newborn | 6 | 2020 | 8223 | 0.220 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 904 | 0.220 |
Why?
|
Adenine Nucleotides | 2 | 2015 | 351 | 0.210 |
Why?
|
Intestinal Mucosa | 1 | 2008 | 1081 | 0.210 |
Why?
|
B-Lymphocytes | 2 | 2013 | 1294 | 0.210 |
Why?
|
Lung Diseases | 2 | 2020 | 717 | 0.210 |
Why?
|
Bone Marrow | 5 | 2021 | 2358 | 0.210 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 5159 | 0.210 |
Why?
|
Case-Control Studies | 7 | 2023 | 6100 | 0.200 |
Why?
|
Liver Failure, Acute | 1 | 2023 | 88 | 0.200 |
Why?
|
Arabinonucleosides | 2 | 2015 | 437 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2359 | 0.200 |
Why?
|
RNA, Messenger | 2 | 2011 | 6150 | 0.200 |
Why?
|
Clinical Trials as Topic | 5 | 2019 | 3719 | 0.200 |
Why?
|
Young Adult | 12 | 2023 | 21445 | 0.200 |
Why?
|
Clinical Decision-Making | 2 | 2022 | 524 | 0.190 |
Why?
|
Growth Disorders | 1 | 2002 | 218 | 0.190 |
Why?
|
DNA | 4 | 2007 | 2693 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2018 | 4849 | 0.190 |
Why?
|
ADP-ribosyl Cyclase 1 | 1 | 2021 | 141 | 0.190 |
Why?
|
Glioma | 2 | 2022 | 1963 | 0.190 |
Why?
|
ADAMTS13 Protein | 1 | 2021 | 92 | 0.190 |
Why?
|
Teratoma | 1 | 2002 | 236 | 0.190 |
Why?
|
Disease Progression | 5 | 2018 | 6682 | 0.190 |
Why?
|
Malawi | 4 | 2023 | 378 | 0.190 |
Why?
|
Wilms Tumor | 1 | 2023 | 292 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2022 | 371 | 0.180 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 14289 | 0.180 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2001 | 171 | 0.180 |
Why?
|
Gastroenteritis | 1 | 2023 | 300 | 0.180 |
Why?
|
Thiotepa | 1 | 2020 | 118 | 0.180 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2023 | 362 | 0.180 |
Why?
|
Pyrazoles | 2 | 2020 | 1471 | 0.180 |
Why?
|
Cell Lineage | 3 | 2023 | 668 | 0.180 |
Why?
|
Mice | 18 | 2021 | 34495 | 0.180 |
Why?
|
CD3 Complex | 2 | 2011 | 314 | 0.180 |
Why?
|
Melphalan | 2 | 2023 | 834 | 0.180 |
Why?
|
Thoracic Neoplasms | 1 | 2002 | 337 | 0.170 |
Why?
|
Janus Kinase Inhibitors | 1 | 2020 | 63 | 0.170 |
Why?
|
Tertiary Healthcare | 1 | 2019 | 44 | 0.170 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 644 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 1489 | 0.170 |
Why?
|
Cellular Senescence | 1 | 2021 | 382 | 0.170 |
Why?
|
Glycoproteins | 2 | 2020 | 747 | 0.170 |
Why?
|
Pneumothorax | 1 | 2020 | 153 | 0.170 |
Why?
|
Transcription, Genetic | 5 | 2003 | 3154 | 0.170 |
Why?
|
Benzimidazoles | 1 | 2022 | 428 | 0.170 |
Why?
|
Retrospective Studies | 16 | 2023 | 37905 | 0.160 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 1688 | 0.160 |
Why?
|
Positron-Emission Tomography | 3 | 2013 | 2173 | 0.160 |
Why?
|
von Willebrand Factor | 1 | 2021 | 335 | 0.160 |
Why?
|
Biliary Tract Diseases | 1 | 2018 | 61 | 0.160 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 6942 | 0.160 |
Why?
|
Mitosis | 1 | 2000 | 615 | 0.160 |
Why?
|
ROC Curve | 2 | 2014 | 1183 | 0.160 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 106 | 0.160 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 2508 | 0.160 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2017 | 24 | 0.160 |
Why?
|
Genome, Human | 2 | 2018 | 1869 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2017 | 1226 | 0.160 |
Why?
|
Mutation, Missense | 2 | 2021 | 1152 | 0.160 |
Why?
|
Leukocytes | 1 | 2020 | 422 | 0.150 |
Why?
|
Proteome | 1 | 2021 | 561 | 0.150 |
Why?
|
Hematology | 1 | 2018 | 104 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 2291 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 7702 | 0.150 |
Why?
|
Brain | 4 | 2023 | 4113 | 0.150 |
Why?
|
Anemia | 1 | 2023 | 689 | 0.150 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 104 | 0.150 |
Why?
|
Apoptosis | 4 | 2021 | 7591 | 0.150 |
Why?
|
Africa South of the Sahara | 3 | 2023 | 101 | 0.150 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2017 | 153 | 0.140 |
Why?
|
Genotype | 2 | 2015 | 4109 | 0.140 |
Why?
|
Histiocytic Disorders, Malignant | 1 | 2016 | 6 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 588 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 129 | 0.140 |
Why?
|
Abnormalities, Multiple | 1 | 2002 | 998 | 0.140 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 2016 | 25 | 0.140 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 1073 | 0.140 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 190 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 198 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 280 | 0.140 |
Why?
|
Genetic Testing | 3 | 2021 | 1589 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2019 | 32848 | 0.140 |
Why?
|
Radiation Pneumonitis | 1 | 2018 | 301 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 1033 | 0.140 |
Why?
|
Hydroxyurea | 1 | 2016 | 204 | 0.130 |
Why?
|
Thiophenes | 1 | 2016 | 148 | 0.130 |
Why?
|
Dexamethasone | 1 | 2020 | 1450 | 0.130 |
Why?
|
RNA Splicing | 1 | 2017 | 370 | 0.130 |
Why?
|
Oncogene Proteins | 1 | 2017 | 354 | 0.130 |
Why?
|
Protein Domains | 1 | 2016 | 314 | 0.130 |
Why?
|
Down-Regulation | 1 | 2000 | 2074 | 0.130 |
Why?
|
Bone Marrow Cells | 2 | 2017 | 943 | 0.130 |
Why?
|
Vaginal Diseases | 1 | 2015 | 26 | 0.130 |
Why?
|
Survival Analysis | 2 | 2018 | 9180 | 0.130 |
Why?
|
Liver Diseases | 2 | 2018 | 574 | 0.130 |
Why?
|
Physicians | 1 | 2023 | 882 | 0.130 |
Why?
|
Signal Transduction | 6 | 2020 | 11965 | 0.130 |
Why?
|
Remission Induction | 3 | 2017 | 3569 | 0.120 |
Why?
|
Drug Substitution | 1 | 2014 | 87 | 0.120 |
Why?
|
Pediatrics | 2 | 2018 | 1141 | 0.120 |
Why?
|
Ataxia Telangiectasia | 1 | 1994 | 62 | 0.120 |
Why?
|
Induction Chemotherapy | 1 | 2018 | 669 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2021 | 1546 | 0.120 |
Why?
|
Salvage Therapy | 2 | 2013 | 2054 | 0.120 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2014 | 71 | 0.120 |
Why?
|
Liver Transplantation | 1 | 2023 | 1112 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2016 | 238 | 0.120 |
Why?
|
Critical Illness | 2 | 2021 | 714 | 0.120 |
Why?
|
Antigens | 1 | 2015 | 292 | 0.120 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2015 | 209 | 0.120 |
Why?
|
GATA2 Transcription Factor | 1 | 2013 | 68 | 0.120 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 2315 | 0.120 |
Why?
|
Family | 1 | 2017 | 736 | 0.110 |
Why?
|
Consensus | 3 | 2023 | 978 | 0.110 |
Why?
|
Vidarabine | 1 | 2018 | 1341 | 0.110 |
Why?
|
Lymph Nodes | 3 | 2020 | 2967 | 0.110 |
Why?
|
Immune System | 1 | 2015 | 279 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 661 | 0.110 |
Why?
|
Immunoprecipitation | 2 | 2011 | 591 | 0.110 |
Why?
|
Medical Oncology | 2 | 2023 | 1423 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 336 | 0.110 |
Why?
|
Mediastinal Diseases | 1 | 2013 | 56 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8873 | 0.110 |
Why?
|
Castleman Disease | 1 | 2013 | 69 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2010 | 1818 | 0.110 |
Why?
|
Phenotype | 4 | 2019 | 6295 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2009 | 3203 | 0.100 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2017 | 833 | 0.100 |
Why?
|
Inflammation | 3 | 2021 | 2522 | 0.100 |
Why?
|
Bone Diseases | 1 | 2012 | 143 | 0.100 |
Why?
|
Cell Division | 2 | 2009 | 2489 | 0.100 |
Why?
|
Parents | 1 | 2018 | 998 | 0.100 |
Why?
|
Mediastinum | 1 | 2013 | 268 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2013 | 1014 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 4892 | 0.100 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 4 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2020 | 18 | 0.090 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2020 | 16 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 10035 | 0.090 |
Why?
|
Texas | 3 | 2018 | 6311 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2020 | 14889 | 0.090 |
Why?
|
Registries | 1 | 2018 | 2170 | 0.090 |
Why?
|
Genes, p53 | 1 | 1994 | 1090 | 0.090 |
Why?
|
Base Sequence | 5 | 2017 | 4917 | 0.090 |
Why?
|
Osteoclasts | 1 | 2011 | 165 | 0.090 |
Why?
|
Algorithms | 1 | 2021 | 3890 | 0.090 |
Why?
|
United States | 7 | 2023 | 15433 | 0.090 |
Why?
|
Research Design | 1 | 2017 | 1544 | 0.090 |
Why?
|
Macrophages | 1 | 2016 | 1304 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 220 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 1258 | 0.090 |
Why?
|
Disease-Free Survival | 3 | 2017 | 10001 | 0.090 |
Why?
|
Exome | 1 | 2015 | 1239 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 7551 | 0.090 |
Why?
|
Osteogenesis | 1 | 2011 | 271 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2054 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 3022 | 0.080 |
Why?
|
DNA Damage | 1 | 2017 | 1954 | 0.080 |
Why?
|
Blotting, Southern | 2 | 2007 | 406 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2017 | 5710 | 0.080 |
Why?
|
Connective Tissue Growth Factor | 1 | 2008 | 45 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 15862 | 0.080 |
Why?
|
Cyclosporine | 1 | 2009 | 278 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 1678 | 0.080 |
Why?
|
Prognosis | 6 | 2019 | 21713 | 0.080 |
Why?
|
Risk Factors | 6 | 2023 | 17523 | 0.080 |
Why?
|
Recombinant Proteins | 3 | 2021 | 2927 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2638 | 0.080 |
Why?
|
Databases, Genetic | 2 | 2019 | 745 | 0.080 |
Why?
|
Accident Prevention | 1 | 1987 | 15 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 1299 | 0.070 |
Why?
|
Bicycling | 1 | 1987 | 38 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 191 | 0.070 |
Why?
|
Physician Executives | 1 | 2006 | 40 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 895 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 1987 | 116 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 3639 | 0.070 |
Why?
|
Sports | 1 | 1987 | 80 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 4053 | 0.070 |
Why?
|
Gene Amplification | 1 | 2009 | 731 | 0.070 |
Why?
|
Athletic Injuries | 1 | 1987 | 97 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 12873 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 4549 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2020 | 1021 | 0.070 |
Why?
|
Immunotherapy | 3 | 2018 | 3341 | 0.070 |
Why?
|
Cohort Studies | 3 | 2020 | 9244 | 0.070 |
Why?
|
Workload | 1 | 2006 | 198 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2017 | 5637 | 0.070 |
Why?
|
Bone and Bones | 1 | 2009 | 619 | 0.070 |
Why?
|
Blotting, Western | 1 | 2011 | 3536 | 0.060 |
Why?
|
Cell Line | 4 | 2011 | 5114 | 0.060 |
Why?
|
Cyclophosphamide | 2 | 2023 | 3001 | 0.060 |
Why?
|
Protein Binding | 4 | 2011 | 3438 | 0.060 |
Why?
|
DNA Primers | 1 | 2007 | 1399 | 0.060 |
Why?
|
Incidence | 3 | 2020 | 5673 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 984 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2015 | 2819 | 0.060 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 22 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 4314 | 0.060 |
Why?
|
Genomics | 3 | 2022 | 2738 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2021 | 4143 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2021 | 1084 | 0.060 |
Why?
|
Aged | 7 | 2016 | 70117 | 0.060 |
Why?
|
Binding Sites | 3 | 2003 | 2171 | 0.060 |
Why?
|
Tanzania | 1 | 2023 | 68 | 0.060 |
Why?
|
Immunoglobulin Joining Region | 1 | 2002 | 14 | 0.060 |
Why?
|
Physical Chromosome Mapping | 1 | 2002 | 73 | 0.060 |
Why?
|
Antibody Diversity | 1 | 2002 | 8 | 0.060 |
Why?
|
DNA Footprinting | 1 | 2002 | 34 | 0.060 |
Why?
|
Base Composition | 1 | 2002 | 92 | 0.050 |
Why?
|
Transfection | 2 | 2000 | 2944 | 0.050 |
Why?
|
Cell Survival | 1 | 2009 | 3045 | 0.050 |
Why?
|
Chimera | 1 | 2002 | 145 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2002 | 78 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2002 | 239 | 0.050 |
Why?
|
Greece | 1 | 2022 | 22 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2021 | 7222 | 0.050 |
Why?
|
Advisory Committees | 1 | 2023 | 203 | 0.050 |
Why?
|
Extremities | 1 | 2023 | 303 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 2403 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 1533 | 0.050 |
Why?
|
Morbidity | 1 | 2023 | 397 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 521 | 0.050 |
Why?
|
Immunoglobulin Variable Region | 1 | 2002 | 173 | 0.050 |
Why?
|
U937 Cells | 1 | 2001 | 171 | 0.050 |
Why?
|
Rats | 2 | 2008 | 6086 | 0.050 |
Why?
|
Middle Aged | 7 | 2016 | 86204 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2021 | 7226 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 332 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2001 | 334 | 0.050 |
Why?
|
Head | 1 | 2022 | 249 | 0.050 |
Why?
|
Fatigue | 2 | 2023 | 1239 | 0.050 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2020 | 15 | 0.050 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2020 | 93 | 0.050 |
Why?
|
Gene Expression | 2 | 2017 | 3570 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 2979 | 0.050 |
Why?
|
Giant Cells | 1 | 2000 | 69 | 0.050 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2021 | 164 | 0.050 |
Why?
|
Pleurodesis | 1 | 2020 | 71 | 0.050 |
Why?
|
Exons | 3 | 2017 | 1328 | 0.050 |
Why?
|
Virus Replication | 1 | 2023 | 709 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2021 | 171 | 0.050 |
Why?
|
Chest Tubes | 1 | 2020 | 101 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2002 | 359 | 0.040 |
Why?
|
Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 4971 | 0.040 |
Why?
|
Survival Rate | 3 | 2017 | 12221 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2020 | 214 | 0.040 |
Why?
|
S100 Proteins | 1 | 2000 | 181 | 0.040 |
Why?
|
Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
Neuroimaging | 1 | 2022 | 403 | 0.040 |
Why?
|
Janus Kinases | 1 | 2020 | 174 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2019 | 148 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 2011 | 6089 | 0.040 |
Why?
|
Capacity Building | 1 | 2018 | 30 | 0.040 |
Why?
|
Busulfan | 1 | 2023 | 764 | 0.040 |
Why?
|
Tissue Donors | 1 | 2023 | 769 | 0.040 |
Why?
|
Blood Cells | 1 | 2019 | 127 | 0.040 |
Why?
|
Drug Resistance | 1 | 2020 | 587 | 0.040 |
Why?
|
Lymphadenopathy | 1 | 2019 | 90 | 0.040 |
Why?
|
Rituximab | 1 | 2024 | 1528 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1064 | 0.040 |
Why?
|
Recurrence | 2 | 2019 | 4758 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 4367 | 0.040 |
Why?
|
Metabolism, Inborn Errors | 1 | 2019 | 108 | 0.040 |
Why?
|
Liver Failure | 1 | 2019 | 140 | 0.040 |
Why?
|
Chimerism | 1 | 2018 | 63 | 0.040 |
Why?
|
Nephrectomy | 1 | 2023 | 779 | 0.040 |
Why?
|
Guillain-Barre Syndrome | 1 | 2018 | 35 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 5395 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2017 | 10331 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1313 | 0.040 |
Why?
|
Patient Care | 1 | 2018 | 149 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2023 | 799 | 0.040 |
Why?
|
Pancytopenia | 1 | 2018 | 120 | 0.040 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 148 | 0.040 |
Why?
|
Foam Cells | 1 | 2017 | 27 | 0.040 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2017 | 86 | 0.040 |
Why?
|
Time Factors | 2 | 2008 | 12926 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2002 | 1694 | 0.040 |
Why?
|
Adenoviridae | 1 | 2023 | 1459 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2019 | 256 | 0.040 |
Why?
|
Age of Onset | 1 | 2019 | 827 | 0.040 |
Why?
|
HeLa Cells | 1 | 2000 | 1643 | 0.040 |
Why?
|
Multiple Organ Failure | 1 | 2018 | 177 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 170 | 0.040 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 96 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2020 | 842 | 0.040 |
Why?
|
Phagocytosis | 1 | 2017 | 260 | 0.040 |
Why?
|
Sirolimus | 1 | 2021 | 814 | 0.040 |
Why?
|
Bleomycin | 1 | 2018 | 467 | 0.040 |
Why?
|
Unrelated Donors | 1 | 2018 | 304 | 0.040 |
Why?
|
Drug Therapy | 1 | 2017 | 205 | 0.040 |
Why?
|
Mexico | 1 | 2016 | 259 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 211 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 2314 | 0.030 |
Why?
|
Nitriles | 1 | 2020 | 906 | 0.030 |
Why?
|
Stem Cells | 1 | 2002 | 1213 | 0.030 |
Why?
|
Cell Cycle Checkpoints | 1 | 2017 | 278 | 0.030 |
Why?
|
Allografts | 1 | 2017 | 650 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2019 | 388 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 408 | 0.030 |
Why?
|
Internship and Residency | 1 | 2006 | 1375 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 503 | 0.030 |
Why?
|
Cause of Death | 1 | 2018 | 752 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1331 | 0.030 |
Why?
|
Streptonigrin | 1 | 1994 | 4 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 421 | 0.030 |
Why?
|
Software | 1 | 2002 | 1321 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2000 | 1620 | 0.030 |
Why?
|
Etoposide | 1 | 2017 | 870 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2019 | 1038 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1998 | 584 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2010 | 611 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 390 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2019 | 698 | 0.030 |
Why?
|
Pain | 1 | 2023 | 1658 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 544 | 0.030 |
Why?
|
Survivors | 1 | 2020 | 1031 | 0.030 |
Why?
|
Etanercept | 1 | 2014 | 54 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 1994 | 133 | 0.030 |
Why?
|
Thrombosis | 1 | 2021 | 781 | 0.030 |
Why?
|
CD11c Antigen | 1 | 2014 | 55 | 0.030 |
Why?
|
Prevalence | 1 | 2022 | 3260 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2011 | 4233 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2017 | 383 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 507 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2017 | 349 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2014 | 184 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2023 | 13658 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 3552 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 182 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2014 | 295 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 2843 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 671 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1681 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2018 | 2231 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2014 | 593 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2001 | 2022 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2014 | 298 | 0.030 |
Why?
|
Clonal Evolution | 1 | 2013 | 253 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2012 | 227 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2011 | 37 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8865 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 3 | 2003 | 1555 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 2437 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2011 | 201 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 1375 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1824 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 461 | 0.020 |
Why?
|
RANK Ligand | 1 | 2011 | 119 | 0.020 |
Why?
|
Femur | 1 | 2011 | 158 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1360 | 0.020 |
Why?
|
Smad Proteins | 1 | 2010 | 88 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 1489 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2014 | 1021 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 508 | 0.020 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 76 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 3842 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 1890 | 0.020 |
Why?
|
Gene Library | 2 | 2001 | 294 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1516 | 0.020 |
Why?
|
Liver | 1 | 2019 | 2961 | 0.020 |
Why?
|
Introns | 2 | 2001 | 432 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2001 | 682 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 734 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 801 | 0.020 |
Why?
|
Mortality | 1 | 2011 | 343 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2011 | 291 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2001 | 1213 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 1301 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 837 | 0.020 |
Why?
|
Fibroblasts | 1 | 1994 | 1682 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 3518 | 0.020 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2009 | 193 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2018 | 4320 | 0.020 |
Why?
|
Lung | 1 | 2018 | 3151 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 7548 | 0.020 |
Why?
|
Quality of Life | 1 | 2020 | 4532 | 0.020 |
Why?
|
Odds Ratio | 1 | 2011 | 2316 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2016 | 29902 | 0.020 |
Why?
|
Pregnancy | 1 | 2018 | 7573 | 0.020 |
Why?
|
Chemoradiotherapy | 1 | 2013 | 1946 | 0.020 |
Why?
|
Risk Assessment | 1 | 2017 | 6869 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.020 |
Why?
|
Radiography | 1 | 2009 | 1904 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 184 | 0.010 |
Why?
|
Aging | 1 | 2011 | 1582 | 0.010 |
Why?
|
Cosmids | 1 | 2001 | 40 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 2488 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2001 | 101 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2001 | 130 | 0.010 |
Why?
|
Poly A | 1 | 2001 | 87 | 0.010 |
Why?
|
VDJ Recombinases | 1 | 2000 | 14 | 0.010 |
Why?
|
TATA Box | 1 | 2000 | 36 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2001 | 250 | 0.010 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2000 | 53 | 0.010 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2000 | 31 | 0.010 |
Why?
|
S100 Calcium-Binding Protein A4 | 1 | 2000 | 57 | 0.010 |
Why?
|
5' Untranslated Regions | 1 | 2000 | 93 | 0.010 |
Why?
|
3T3 Cells | 1 | 2000 | 355 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2000 | 354 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 304 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2001 | 327 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 869 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 875 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 997 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2000 | 469 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 826 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 842 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 844 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 1487 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2000 | 622 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2006 | 5687 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2000 | 3343 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2000 | 7789 | 0.000 |
Why?
|